- Home
- GGB vs GRFS Comparison
GGB vs GRFS Comparison
Compare GGB & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGB
- GRFS
- Stock Information
- Founded
- GGB 1901
- GRFS 1940
- Country
- GGB Brazil
- GRFS Spain
- Employees
- GGB N/A
- GRFS N/A
- Industry
- GGB Steel/Iron Ore
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- GGB Industrials
- GRFS Health Care
- Exchange
- GGB Nasdaq
- GRFS Nasdaq
- Market Cap
- GGB 6.2B
- GRFS 5.1B
- IPO Year
- GGB 1999
- GRFS 2006
- Fundamental
- Price
- GGB $2.83
- GRFS $7.45
- Analyst Decision
- GGB Strong Buy
- GRFS Strong Sell
- Analyst Count
- GGB 2
- GRFS 1
- Target Price
- GGB $5.00
- GRFS N/A
- AVG Volume (30 Days)
- GGB 9.6M
- GRFS 803.0K
- Earning Date
- GGB 02-19-2025
- GRFS 01-01-0001
- Dividend Yield
- GGB 4.99%
- GRFS N/A
- EPS Growth
- GGB N/A
- GRFS N/A
- EPS
- GGB 0.36
- GRFS 0.27
- Revenue
- GGB $10,837,144,685.00
- GRFS $7,814,096,584.00
- Revenue This Year
- GGB N/A
- GRFS $9.53
- Revenue Next Year
- GGB $6.15
- GRFS $8.09
- P/E Ratio
- GGB $7.62
- GRFS $33.40
- Revenue Growth
- GGB N/A
- GRFS 7.21
- 52 Week Low
- GGB $2.67
- GRFS $5.30
- 52 Week High
- GGB $4.04
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- GGB 40.33
- GRFS 54.19
- Support Level
- GGB $2.95
- GRFS $7.35
- Resistance Level
- GGB $3.08
- GRFS $7.61
- Average True Range (ATR)
- GGB 0.08
- GRFS 0.21
- MACD
- GGB -0.01
- GRFS 0.07
- Stochastic Oscillator
- GGB 5.00
- GRFS 82.35
About GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutor, mechanical construction bars, reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives majority of the revenue from the North America Operations segment.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.